The National Council on Prices and Reimbursement of Medicinal Products carries out an Nealth Technology Assessment of the medicinal products, on the grounds of Art. 259, para 1, item 6 of MEDICINAL PRODUCTS IN HUMAN MEDICINE ACT (SG, issue 102 of 2018, in force from 01.01.2019) and art. 1, item 8 and Chapter Six of the ORDINANCE ON THE TERMS, RULES AND PROCEDURE FOR REGULATION AND REGISTRATION OF PRICES FOR MEDICINAL PRODUCTS (SG, issue 26 of 2019, in force from 01.04.2019)